TSG6_RABIT
ID TSG6_RABIT Reviewed; 276 AA.
AC P98065;
DT 01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT 01-FEB-1996, sequence version 1.
DT 03-AUG-2022, entry version 126.
DE RecName: Full=Tumor necrosis factor-inducible gene 6 protein;
DE EC=3.1.1.- {ECO:0000250|UniProtKB:P98066};
DE AltName: Full=Hyaluronate-binding protein PS4;
DE AltName: Full=TNF-stimulated gene 6 protein;
DE Short=TSG-6;
DE AltName: Full=Tumor necrosis factor alpha-induced protein 6;
DE Short=TNF alpha-induced protein 6;
DE Flags: Precursor;
GN Name=TNFAIP6; Synonyms=PS4, TSG6;
OS Oryctolagus cuniculus (Rabbit).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae; Oryctolagus.
OX NCBI_TaxID=9986;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, AND
RP INDUCTION BY GROWTH FACTORS.
RC STRAIN=New Zealand white;
RX PubMed=8098034; DOI=10.1016/s0021-9258(18)98362-6;
RA Feng P., Liau G.;
RT "Identification of a novel serum and growth factor-inducible gene in
RT vascular smooth muscle cells.";
RL J. Biol. Chem. 268:9387-9392(1993).
RN [2]
RP ERRATUM OF PUBMED:8098034.
RX PubMed=8407990; DOI=10.1016/s0021-9258(19)36946-7;
RA Feng P., Liau G.;
RL J. Biol. Chem. 268:21453-21453(1993).
CC -!- FUNCTION: Major regulator of extracellular matrix organization during
CC tissue remodeling (By similarity). Catalyzes the transfer of a heavy
CC chain (HC) from inter-alpha-inhibitor (I-alpha-I) complex to
CC hyaluronan. Cleaves the ester bond between the C-terminus of the HC and
CC GalNAc residue of the chondroitin sulfate chain in I-alpha-I complex
CC followed by transesterification of the HC to hyaluronan. In the
CC process, potentiates the antiprotease function of I-alpha-I complex
CC through release of free bikunin (By similarity). Acts as a catalyst in
CC the formation of hyaluronan-HC oligomers and hyaluronan-rich matrix
CC surrounding the cumulus cell-oocyte complex, a necessary step for
CC oocyte fertilization (By similarity). Assembles hyaluronan in
CC pericellular matrices that serve as platforms for receptor clustering
CC and signaling. Enables binding of hyaluronan deposited on the surface
CC of macrophages to LYVE1 on lymphatic endothelium and facilitates
CC macrophage extravasation. Alters hyaluronan binding to functionally
CC latent CD44 on vascular endothelium, switching CD44 into an active
CC state that supports leukocyte rolling (By similarity). Modulates the
CC interaction of chemokines with extracellular matrix components and
CC proteoglycans on endothelial cell surface, likely preventing chemokine
CC gradient formation. In a negative feedback mechanism, may limit
CC excessive neutrophil recruitment at inflammatory sites by antagonizing
CC the association of CXCL8 with glycosaminoglycans on vascular
CC endothelium (By similarity). Has a role in osteogenesis and bone
CC remodeling. Inhibits BMP2-dependent differentiation of mesenchymal stem
CC cell to osteoblasts. Protects against bone erosion during inflammation
CC by inhibiting TNFSF11/RANKL-dependent osteoclast activation (By
CC similarity). {ECO:0000250|UniProtKB:O08859,
CC ECO:0000250|UniProtKB:P98066}.
CC -!- SUBUNIT: Interacts (via Link domain) with inter-alpha-inhibitor (I-
CC alpha-I) component bikunin. Interacts with ITIH2/HC2; this interaction
CC is required for transesterification of the HC to hyaluronan. Interacts
CC (via Link and CUB domains) with ITIH1. Chondroitin sulfate may be
CC required for the stability of the complex. Interacts (via Link domain)
CC with various C-X-C and C-C chemokines including PF4, CXCL8, CXCL11,
CC CXCL12, CCL2, CCL7, CCL19, CCL21, and CCL27; this interaction
CC interferes with chemokine binding to glycosaminoglycans. Interacts
CC (primarily via Link domain) with BMP2; this interaction is inhibited by
CC hyaluronan. Interacts (via both Link and CUB domains) with TNFSF11.
CC Interacts (via CUB domain) with FN1 (via type III repeats 9-14); this
CC interaction enhances fibronectin fibril assembly. TNFAIP6 may act as a
CC bridging molecule between FN1 and THBS1.
CC {ECO:0000250|UniProtKB:P98066}.
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:P98066}.
CC -!- TISSUE SPECIFICITY: Vascular smooth muscle cells.
CC {ECO:0000269|PubMed:8098034}.
CC -!- DEVELOPMENTAL STAGE: Fetal skeletal muscle, esophagus, kidney, and
CC lung. {ECO:0000269|PubMed:8098034}.
CC -!- INDUCTION: By serum and growth factors. {ECO:0000269|PubMed:8098034}.
CC -!- DOMAIN: The Link domain interacts with various extracellular matrix
CC components, including heparin, heparan sulfates, hyaluronan and I-
CC alpha-I complex. It is required for binding to various chemokines.
CC {ECO:0000250|UniProtKB:P98066}.
CC -!- DOMAIN: The CUB domain is necessary for calcium ion binding and
CC transesterification reaction. It is required for binding to FN1.
CC {ECO:0000250|UniProtKB:P98066}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; M86381; AAA03342.1; -; mRNA.
DR PIR; A48055; A47290.
DR RefSeq; NP_001075780.1; NM_001082311.1.
DR AlphaFoldDB; P98065; -.
DR BMRB; P98065; -.
DR SMR; P98065; -.
DR STRING; 9986.ENSOCUP00000011779; -.
DR PRIDE; P98065; -.
DR Ensembl; ENSOCUT00000013688; ENSOCUP00000011779; ENSOCUG00000013688.
DR GeneID; 100009149; -.
DR KEGG; ocu:100009149; -.
DR CTD; 7130; -.
DR eggNOG; KOG1218; Eukaryota.
DR eggNOG; KOG3714; Eukaryota.
DR GeneTree; ENSGT00940000157201; -.
DR HOGENOM; CLU_092089_0_0_1; -.
DR InParanoid; P98065; -.
DR OMA; DDTACMA; -.
DR OrthoDB; 934805at2759; -.
DR TreeFam; TF334173; -.
DR Proteomes; UP000001811; Chromosome 7.
DR Bgee; ENSOCUG00000013688; Expressed in ovary and 11 other tissues.
DR GO; GO:0005576; C:extracellular region; ISS:UniProtKB.
DR GO; GO:0005509; F:calcium ion binding; ISS:UniProtKB.
DR GO; GO:0052689; F:carboxylic ester hydrolase activity; ISS:UniProtKB.
DR GO; GO:0001968; F:fibronectin binding; ISS:UniProtKB.
DR GO; GO:0005540; F:hyaluronic acid binding; ISS:UniProtKB.
DR GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR GO; GO:1905590; P:fibronectin fibril organization; ISS:UniProtKB.
DR GO; GO:0030212; P:hyaluronan metabolic process; ISS:UniProtKB.
DR GO; GO:0030514; P:negative regulation of BMP signaling pathway; ISS:UniProtKB.
DR GO; GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl.
DR GO; GO:0090024; P:negative regulation of neutrophil chemotaxis; ISS:UniProtKB.
DR GO; GO:0045668; P:negative regulation of osteoblast differentiation; ISS:UniProtKB.
DR GO; GO:0045671; P:negative regulation of osteoclast differentiation; ISS:UniProtKB.
DR GO; GO:0001550; P:ovarian cumulus expansion; ISS:UniProtKB.
DR GO; GO:1903911; P:positive regulation of receptor clustering; ISS:UniProtKB.
DR CDD; cd00041; CUB; 1.
DR Gene3D; 2.60.120.290; -; 1.
DR Gene3D; 3.10.100.10; -; 1.
DR InterPro; IPR016186; C-type_lectin-like/link_sf.
DR InterPro; IPR016187; CTDL_fold.
DR InterPro; IPR000859; CUB_dom.
DR InterPro; IPR000538; Link_dom.
DR InterPro; IPR035914; Sperma_CUB_dom_sf.
DR Pfam; PF00431; CUB; 1.
DR Pfam; PF00193; Xlink; 1.
DR PRINTS; PR01265; LINKMODULE.
DR SMART; SM00042; CUB; 1.
DR SMART; SM00445; LINK; 1.
DR SUPFAM; SSF49854; SSF49854; 1.
DR SUPFAM; SSF56436; SSF56436; 1.
DR PROSITE; PS01180; CUB; 1.
DR PROSITE; PS01241; LINK_1; 1.
DR PROSITE; PS50963; LINK_2; 1.
PE 2: Evidence at transcript level;
KW Calcium; Cell adhesion; Disulfide bond; Glycoprotein; Hydrolase;
KW Metal-binding; Reference proteome; Secreted; Signal.
FT SIGNAL 1..17
FT /evidence="ECO:0000255"
FT CHAIN 18..276
FT /note="Tumor necrosis factor-inducible gene 6 protein"
FT /evidence="ECO:0000255"
FT /id="PRO_0000026694"
FT DOMAIN 36..129
FT /note="Link"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00323"
FT DOMAIN 135..247
FT /note="CUB"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT BINDING 183
FT /ligand="Ca(2+)"
FT /ligand_id="ChEBI:CHEBI:29108"
FT /evidence="ECO:0000250|UniProtKB:P98066"
FT BINDING 191
FT /ligand="Ca(2+)"
FT /ligand_id="ChEBI:CHEBI:29108"
FT /evidence="ECO:0000250|UniProtKB:P98066"
FT BINDING 232
FT /ligand="Ca(2+)"
FT /ligand_id="ChEBI:CHEBI:29108"
FT /evidence="ECO:0000250|UniProtKB:P98066"
FT BINDING 234
FT /ligand="Ca(2+)"
FT /ligand_id="ChEBI:CHEBI:29108"
FT /evidence="ECO:0000250|UniProtKB:P98066"
FT BINDING 235
FT /ligand="Ca(2+)"
FT /ligand_id="ChEBI:CHEBI:29108"
FT /evidence="ECO:0000250|UniProtKB:P98066"
FT CARBOHYD 118
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 258
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT DISULFID 58..127
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00323"
FT DISULFID 82..103
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00323"
FT DISULFID 135..161
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT DISULFID 188..210
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
SQ SEQUENCE 276 AA; 31081 MW; 3BDC5D9A24B2F75A CRC64;
MIILIYLFVL VWEEAQGWGF KNGIFHNSIW LEQAAGVYHR EARSGKYKLT YAEAKAVCEF
EGGRLATYKQ LEAARKIGFH VCAAGWMAKG RVGYPIVKPG SNCGFGKTGI IDYGIRLNRS
ERWDAYCYNP HAKECGGVFT DPKRIFKSPG FPNEYDDNQI CYWHIRLKYG QRIHLSFLNF
DLEYDPGCLA DYVEIYDSYD DVHGFVGRYC GDELPEDIIS TGNVMTLKFL SDASVTAGGF
QIKYVTVDPA SKSSQGKNTS TVSGNKNFLA GRFSHL